Selected research
Market Analysis & Forecast
Global Cannabinoid Profiling Market Analysis and Forecast 2026-2032
Market perspective
The global Cannabinoid Profiling market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cannabinoid Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cannabinoid Profiling include Saskatchewan Research Council (SRC), SC Labs, Steep Hill, SGS Canada, CW ANALYTICAL, PharmLabs, GreenLeaf Lab, Kaycha Holdings and American Clinical Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cannabinoid Profiling, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cannabinoid Profiling, also provides the revenue of main regions and countries. Of the upcoming market potential for Cannabinoid Profiling, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cannabinoid Profiling revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cannabinoid Profiling market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cannabinoid Profiling revenue, projected growth trends, production technology, application and end-user industry.
Cannabinoid Profiling Segment by Company
Saskatchewan Research Council (SRC)
SC Labs
Steep Hill
SGS Canada
CW ANALYTICAL
PharmLabs
GreenLeaf Lab
Kaycha Holdings
American Clinical Solutions
CannaSafe
Aurum Labs
A&L Canada Laboratories
Royalmount Laboratories
Confidence Analytics
ACT Laboratories
Cannabinoid Profiling Segment by Type
Gas Chromatography
Liquid Chromatography
Cannabinoid Profiling Segment by Application
Cannabis Drug Manufacturers
Cannabis Cultivators/Growers
Research Institutes
Others
Cannabinoid Profiling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid Profiling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cannabinoid Profiling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cannabinoid Profiling company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabinoid Profiling revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gas Chromatography
- Liquid Chromatography
Applications
- Cannabis Drug Manufacturers
- Cannabis Cultivators/Growers
- Research Institutes
- Others
Companies covered
- Saskatchewan Research Council (SRC)
- SC Labs
- Steep Hill
- SGS Canada
- CW ANALYTICAL
- PharmLabs
- GreenLeaf Lab
- Kaycha Holdings
- American Clinical Solutions
- CannaSafe
- Aurum Labs
- A&L Canada Laboratories
- Royalmount Laboratories
- Confidence Analytics
- ACT Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cannabinoid Profiling Market by Type
- 1.2.1 Global Cannabinoid Profiling Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Gas Chromatography
- 1.2.3 Liquid Chromatography
- 1.3 Cannabinoid Profiling Market by Application
- 1.3.1 Global Cannabinoid Profiling Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Cannabis Drug Manufacturers
- 1.3.3 Cannabis Cultivators/Growers
- 1.3.4 Research Institutes
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cannabinoid Profiling Market Dynamics
- 2.1 Cannabinoid Profiling Industry Trends
- 2.2 Cannabinoid Profiling Industry Drivers
- 2.3 Cannabinoid Profiling Industry Opportunities and Challenges
- 2.4 Cannabinoid Profiling Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cannabinoid Profiling Market Perspective (2021-2032)
- 3.2 Global Cannabinoid Profiling Growth Trends by Region
- 3.2.1 Global Cannabinoid Profiling Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cannabinoid Profiling Market Size by Region (2021-2026)
- 3.2.3 Global Cannabinoid Profiling Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cannabinoid Profiling Revenue by Players
- 4.1.1 Global Cannabinoid Profiling Revenue by Players (2021-2026)
- 4.1.2 Global Cannabinoid Profiling Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cannabinoid Profiling Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cannabinoid Profiling Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cannabinoid Profiling Key Players Headquarters & Area Served
- 4.4 Global Cannabinoid Profiling Players, Product Type & Application
- 4.5 Global Cannabinoid Profiling Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cannabinoid Profiling Market CR5 and HHI
- 4.6.3 2025 Cannabinoid Profiling Tier 1, Tier 2, and Tier 3
5 Cannabinoid Profiling Market Size by Type
- 5.1 Global Cannabinoid Profiling Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cannabinoid Profiling Revenue by Type (2021-2032)
- 5.3 Global Cannabinoid Profiling Revenue Market Share by Type (2021-2032)
6 Cannabinoid Profiling Market Size by Application
- 6.1 Global Cannabinoid Profiling Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cannabinoid Profiling Revenue by Application (2021-2032)
- 6.3 Global Cannabinoid Profiling Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Saskatchewan Research Council (SRC)
- 7.1.1 Saskatchewan Research Council (SRC) Company Information
- 7.1.2 Saskatchewan Research Council (SRC) Business Overview
- 7.1.3 Saskatchewan Research Council (SRC) Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.1.4 Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio
- 7.1.5 Saskatchewan Research Council (SRC) Recent Developments
- 7.2 SC Labs
- 7.2.1 SC Labs Company Information
- 7.2.2 SC Labs Business Overview
- 7.2.3 SC Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.2.4 SC Labs Cannabinoid Profiling Product Portfolio
- 7.2.5 SC Labs Recent Developments
- 7.3 Steep Hill
- 7.3.1 Steep Hill Company Information
- 7.3.2 Steep Hill Business Overview
- 7.3.3 Steep Hill Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.3.4 Steep Hill Cannabinoid Profiling Product Portfolio
- 7.3.5 Steep Hill Recent Developments
- 7.4 SGS Canada
- 7.4.1 SGS Canada Company Information
- 7.4.2 SGS Canada Business Overview
- 7.4.3 SGS Canada Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.4.4 SGS Canada Cannabinoid Profiling Product Portfolio
- 7.4.5 SGS Canada Recent Developments
- 7.5 CW ANALYTICAL
- 7.5.1 CW ANALYTICAL Company Information
- 7.5.2 CW ANALYTICAL Business Overview
- 7.5.3 CW ANALYTICAL Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.5.4 CW ANALYTICAL Cannabinoid Profiling Product Portfolio
- 7.5.5 CW ANALYTICAL Recent Developments
- 7.6 PharmLabs
- 7.6.1 PharmLabs Company Information
- 7.6.2 PharmLabs Business Overview
- 7.6.3 PharmLabs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.6.4 PharmLabs Cannabinoid Profiling Product Portfolio
- 7.6.5 PharmLabs Recent Developments
- 7.7 GreenLeaf Lab
- 7.7.1 GreenLeaf Lab Company Information
- 7.7.2 GreenLeaf Lab Business Overview
- 7.7.3 GreenLeaf Lab Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.7.4 GreenLeaf Lab Cannabinoid Profiling Product Portfolio
- 7.7.5 GreenLeaf Lab Recent Developments
- 7.8 Kaycha Holdings
- 7.8.1 Kaycha Holdings Company Information
- 7.8.2 Kaycha Holdings Business Overview
- 7.8.3 Kaycha Holdings Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.8.4 Kaycha Holdings Cannabinoid Profiling Product Portfolio
- 7.8.5 Kaycha Holdings Recent Developments
- 7.9 American Clinical Solutions
- 7.9.1 American Clinical Solutions Company Information
- 7.9.2 American Clinical Solutions Business Overview
- 7.9.3 American Clinical Solutions Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.9.4 American Clinical Solutions Cannabinoid Profiling Product Portfolio
- 7.9.5 American Clinical Solutions Recent Developments
- 7.10 CannaSafe
- 7.10.1 CannaSafe Company Information
- 7.10.2 CannaSafe Business Overview
- 7.10.3 CannaSafe Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.10.4 CannaSafe Cannabinoid Profiling Product Portfolio
- 7.10.5 CannaSafe Recent Developments
- 7.11 Aurum Labs
- 7.11.1 Aurum Labs Company Information
- 7.11.2 Aurum Labs Business Overview
- 7.11.3 Aurum Labs Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.11.4 Aurum Labs Cannabinoid Profiling Product Portfolio
- 7.11.5 Aurum Labs Recent Developments
- 7.12 A&L Canada Laboratories
- 7.12.1 A&L Canada Laboratories Company Information
- 7.12.2 A&L Canada Laboratories Business Overview
- 7.12.3 A&L Canada Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.12.4 A&L Canada Laboratories Cannabinoid Profiling Product Portfolio
- 7.12.5 A&L Canada Laboratories Recent Developments
- 7.13 Royalmount Laboratories
- 7.13.1 Royalmount Laboratories Company Information
- 7.13.2 Royalmount Laboratories Business Overview
- 7.13.3 Royalmount Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.13.4 Royalmount Laboratories Cannabinoid Profiling Product Portfolio
- 7.13.5 Royalmount Laboratories Recent Developments
- 7.14 Confidence Analytics
- 7.14.1 Confidence Analytics Company Information
- 7.14.2 Confidence Analytics Business Overview
- 7.14.3 Confidence Analytics Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.14.4 Confidence Analytics Cannabinoid Profiling Product Portfolio
- 7.14.5 Confidence Analytics Recent Developments
- 7.15 ACT Laboratories
- 7.15.1 ACT Laboratories Company Information
- 7.15.2 ACT Laboratories Business Overview
- 7.15.3 ACT Laboratories Cannabinoid Profiling Revenue and Gross Margin (2021-2026)
- 7.15.4 ACT Laboratories Cannabinoid Profiling Product Portfolio
- 7.15.5 ACT Laboratories Recent Developments
8 North America
- 8.1 North America Cannabinoid Profiling Revenue (2021-2032)
- 8.2 North America Cannabinoid Profiling Revenue by Type (2021-2032)
- 8.2.1 North America Cannabinoid Profiling Revenue by Type (2021-2026)
- 8.2.2 North America Cannabinoid Profiling Revenue by Type (2027-2032)
- 8.3 North America Cannabinoid Profiling Revenue Share by Type (2021-2032)
- 8.4 North America Cannabinoid Profiling Revenue by Application (2021-2032)
- 8.4.1 North America Cannabinoid Profiling Revenue by Application (2021-2026)
- 8.4.2 North America Cannabinoid Profiling Revenue by Application (2027-2032)
- 8.5 North America Cannabinoid Profiling Revenue Share by Application (2021-2032)
- 8.6 North America Cannabinoid Profiling Revenue by Country
- 8.6.1 North America Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cannabinoid Profiling Revenue by Country (2021-2026)
- 8.6.3 North America Cannabinoid Profiling Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cannabinoid Profiling Revenue (2021-2032)
- 9.2 Europe Cannabinoid Profiling Revenue by Type (2021-2032)
- 9.2.1 Europe Cannabinoid Profiling Revenue by Type (2021-2026)
- 9.2.2 Europe Cannabinoid Profiling Revenue by Type (2027-2032)
- 9.3 Europe Cannabinoid Profiling Revenue Share by Type (2021-2032)
- 9.4 Europe Cannabinoid Profiling Revenue by Application (2021-2032)
- 9.4.1 Europe Cannabinoid Profiling Revenue by Application (2021-2026)
- 9.4.2 Europe Cannabinoid Profiling Revenue by Application (2027-2032)
- 9.5 Europe Cannabinoid Profiling Revenue Share by Application (2021-2032)
- 9.6 Europe Cannabinoid Profiling Revenue by Country
- 9.6.1 Europe Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cannabinoid Profiling Revenue by Country (2021-2026)
- 9.6.3 Europe Cannabinoid Profiling Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cannabinoid Profiling Revenue (2021-2032)
- 10.2 China Cannabinoid Profiling Revenue by Type (2021-2032)
- 10.2.1 China Cannabinoid Profiling Revenue by Type (2021-2026)
- 10.2.2 China Cannabinoid Profiling Revenue by Type (2027-2032)
- 10.3 China Cannabinoid Profiling Revenue Share by Type (2021-2032)
- 10.4 China Cannabinoid Profiling Revenue by Application (2021-2032)
- 10.4.1 China Cannabinoid Profiling Revenue by Application (2021-2026)
- 10.4.2 China Cannabinoid Profiling Revenue by Application (2027-2032)
- 10.5 China Cannabinoid Profiling Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cannabinoid Profiling Revenue (2021-2032)
- 11.2 Asia Cannabinoid Profiling Revenue by Type (2021-2032)
- 11.2.1 Asia Cannabinoid Profiling Revenue by Type (2021-2026)
- 11.2.2 Asia Cannabinoid Profiling Revenue by Type (2027-2032)
- 11.3 Asia Cannabinoid Profiling Revenue Share by Type (2021-2032)
- 11.4 Asia Cannabinoid Profiling Revenue by Application (2021-2032)
- 11.4.1 Asia Cannabinoid Profiling Revenue by Application (2021-2026)
- 11.4.2 Asia Cannabinoid Profiling Revenue by Application (2027-2032)
- 11.5 Asia Cannabinoid Profiling Revenue Share by Application (2021-2032)
- 11.6 Asia Cannabinoid Profiling Revenue by Country
- 11.6.1 Asia Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cannabinoid Profiling Revenue by Country (2021-2026)
- 11.6.3 Asia Cannabinoid Profiling Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cannabinoid Profiling Revenue (2021-2032)
- 12.2 SAMEA Cannabinoid Profiling Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cannabinoid Profiling Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cannabinoid Profiling Revenue by Type (2027-2032)
- 12.3 SAMEA Cannabinoid Profiling Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cannabinoid Profiling Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cannabinoid Profiling Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cannabinoid Profiling Revenue by Application (2027-2032)
- 12.5 SAMEA Cannabinoid Profiling Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cannabinoid Profiling Revenue by Country
- 12.6.1 SAMEA Cannabinoid Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cannabinoid Profiling Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cannabinoid Profiling Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst